STOCK TITAN

Auxly Cannabis Stock Price, News & Analysis

CBWTF OTC

Welcome to our dedicated page for Auxly Cannabis news (Ticker: CBWTF), a resource for investors and traders seeking the latest updates and insights on Auxly Cannabis stock.

Auxly Cannabis Group Inc. (CBWTF) is a leading Canadian cannabis producer focused on premium consumer packaged goods, from dried flower to innovative vape systems. This news hub provides investors and industry observers with verified updates on corporate developments, financial results, and market strategies.

Access timely announcements including quarterly earnings reports, production facility expansions, and new product launches. Our curated collection features official press releases alongside third-party analysis of Auxly's operational milestones in Canada's regulated cannabis market.

Key coverage areas include cultivation efficiency improvements at the Leamington facility, distribution partnerships, and regulatory compliance updates. Stay informed about Auxly's consumer-focused innovation strategy and financial positioning through primary source documents and expert commentary.

Bookmark this page for streamlined access to Auxly's evolving story in the competitive cannabis CPG sector. Check regularly for updates on operational metrics, leadership changes, and product portfolio developments that shape the company's market trajectory.

Rhea-AI Summary
Auxly Cannabis Group (CBWTF) has announced two significant financial agreements to strengthen its balance sheet and reduce debt. First, the company entered a non-binding agreement to amend its BMO-led credit facility, which includes a $50.7M facility consisting of a $36.2M term loan, $10M revolving facility, and $4.5M in equipment leases. Second, Auxly reached an exchange agreement with Imperial Brands to settle over $21M in convertible debenture debt through share issuance and pre-funded warrants. The agreement includes converting $1M principal into 1.23M shares at $0.81/share, $1.39M of accrued interest into shares at $0.0811/share, and issuing warrants for up to 90.88M shares. Upon completion, Imperial Brands will own approximately 19.9% of outstanding shares. These transactions aim to improve Auxly's capital structure, reduce interest obligations, and enhance financial stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Auxly Cannabis Group (CBWTF) has announced its Annual General Meeting of Shareholders scheduled for June 30, 2025, at 10:00 a.m. EST. The meeting will be held at McCarthy Tétrault LLP offices in Toronto. Due to limited seating, shareholders must pre-register via email at IR@auxly.com at least 48 hours before the meeting to attend in person. The company will provide an audio teleconference for remote attendance through North American Toll Free: 1-888-699-1199. However, shareholders participating via teleconference cannot vote during the meeting and are encouraged to vote in advance according to the instructions in the Management Information Circular, available on SEDAR+ and the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
none
-
News
Rhea-AI Summary
Auxly Cannabis Group (CBWTF) reported strong Q1 2025 financial results with net revenues of $32.7 million, up 29% year-over-year. The company achieved an Adjusted EBITDA of $7.4 million (23% of net revenue), representing a 232% increase from Q1 2024. Gross margin improved to 48%, up from 38% in 2024. The company reported net income of $12.1 million, compared to a loss of $26 million in Q1 2024. Back Forty emerged as Canada's #1 cannabis brand, with Auxly holding the #4 position among Canadian Licensed Producers with 5.8% market share. The company reduced debt by 5% from end of 2024 and maintained $17.1 million in cash at quarter end. Sales were driven by dried flower and pre-roll products (63% of revenue), with 75% of sales originating from British Columbia, Alberta, and Ontario.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
Rhea-AI Summary

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) has announced it will release its Q1 2025 financial results on Thursday, May 15, 2025, before market open. The company has stated it will not hold an earnings conference call and does not plan to reinstate earnings calls in the near future. Investors are directed to send their inquiries to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
conferences earnings
-
Rhea-AI Summary

Auxly Cannabis Group (CBWTF) reported strong financial results for Q4 and full year 2024, achieving record sales and profitability. Net revenue reached $122.3 million for the year, up 21% from 2023, with Q4 revenue of $34.6 million, increasing 29% year-over-year.

Key financial highlights include improved gross margins on finished cannabis inventory (54% in Q4 2024 vs 40% in 2023), reduced SG&A expenses by 8% to $35.7 million, and Adjusted EBITDA of $26.7 million (22% of net revenue). The company significantly strengthened its balance sheet by reducing total debt by 56% through conversion of over $123 million into shares.

Notable operational achievements include:

  • Back Forty becoming the #1 cannabis brand in Canada by end of 2024
  • 4th largest Canadian Licensed Producer with 6.0% market share
  • Leading position in non-infused pre-roll category
  • Back Forty all-in-one vape winning 'Innovation of the Year' at 2024 KIND awards

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
Rhea-AI Summary

Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF) has announced it will release its Q4 and full-year 2024 financial results on March 20, 2025, before market open. The company has stated it will not hold an earnings conference call and does not plan to reinstate earnings calls until further notice. Investors are directed to send inquiries to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
conferences earnings
Rhea-AI Summary

Auxly Cannabis Group (OTCQB: CBWTF) reported record-breaking Q3 2024 financial results with net revenues of $33.3 million, up 18% year-over-year. The company achieved a gross margin of 47% and record adjusted EBITDA of $8.3 million. Net income was $3.2 million with operating cash flow of $12.9 million. The company reduced its debt by 54% compared to end of 2023. Auxly moved to #4 position in national recreational sales, leading the all-in-one vape category with 36% market share. Back Forty's Liquid Imagination became the #1 selling flower nationally, while pre-roll sales increased 19% quarter-over-quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
-
Rhea-AI Summary

Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF) has announced it will release its third quarter 2024 financial results on Friday, November 8, 2024, before market open. The results will cover the period ended September 30, 2024. The company has directed all investor inquiries to IR@auxly.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.49%
Tags
conferences earnings
-
Rhea-AI Summary

Auxly Cannabis Group reported record revenue and profitability for Q2 2024. Net revenues reached $29.2 million, a 33% increase year-over-year and a 16% rise from the previous quarter. Gross Margin on Finished Cannabis Inventory Sold hit an all-time high of 41%, a 14% improvement year-over-year. Adjusted EBITDA surged by over 580% to $5.2 million. SG&A expenses were slightly reduced by $0.2 million compared to the same period in 2023, net of restructuring costs. Net income stood at $2.0 million, with positive cash flow from operations of $2.9 million. The company reported a 48% reduction in debt compared to the end of 2023. Auxly maintained its market leadership in the all-in-one vape category, securing over 32% of the total market share. The Back Forty brand continued to dominate with the top four all-in-one vape SKUs and achieved strong performance in dried flower and pre-rolls. Despite the gains, Auxly reported a net loss of $24.0 million for the six months ended June 30, 2024, including deferred tax expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
Rhea-AI Summary

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) has announced that it will release its second quarter 2024 financial results on Thursday, August 15, 2024, before the financial markets open. The report will cover the period ended June 30, 2024. This announcement serves as a notice to investors and analysts who are interested in the company's financial performance. Auxly has directed all investor inquiries to be sent to IR@auxly.com. The announcement was made by CEO Hugo Alves on behalf of the board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.7%
Tags
conferences earnings

FAQ

What is the current stock price of Auxly Cannabis (CBWTF)?

The current stock price of Auxly Cannabis (CBWTF) is $0.0583 as of June 18, 2025.

What is the market cap of Auxly Cannabis (CBWTF)?

The market cap of Auxly Cannabis (CBWTF) is approximately 68.7M.
Auxly Cannabis

OTC:CBWTF

CBWTF Rankings

CBWTF Stock Data

68.67M
1.01B
21.23%
0.16%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Toronto